[Therapeutic possibilities in the treatment of cutaneous lymphomas].
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D006801:Humans; D007937:Leukapheresis; D008466:Mechlorethamine / Q000627:therapeutic use; D009182:Mycosis Fungoides / Q000532:radiotherapy / Q000628:therapy*; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D014165:Transfer Factor / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D001500:BCG Vaccine; D009607:Nitrosourea Compounds; D014165:Transfer Factor; D001761:Bleomycin; D008466:Mechlorethamine
Therapeutische Möglichkeiten bei der Behandlung kutaner Lymphome.